| 2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice … PA Heidenreich, B Bozkurt, D Aguilar, LA Allen, JJ Byun, MM Colvin, ... Journal of the American College of Cardiology 79 (17), e263-e421, 2022 | 7081* | 2022 |
| Renin–angiotensin–aldosterone system inhibitors in patients with Covid-19 M Vaduganathan, O Vardeny, T Michel, JJV McMurray, MA Pfeffer, ... New England Journal of Medicine 382 (17), 1653-1659, 2020 | 2707 | 2020 |
| Potential effects of coronaviruses on the cardiovascular system: a review M Madjid, P Safavi-Naeini, SD Solomon, O Vardeny JAMA cardiology 5 (7), 831-840, 2020 | 2390 | 2020 |
| Universal definition and classification of heart failure: a report of the heart failure society of America, heart failure association of the European society of cardiology … B Bozkurt, AJS Coats, H Tsutsui, M Abdelhamid, S Adamopoulos, N Albert, ... Journal of cardiac failure 27 (4), 387-413, 2021 | 2126 | 2021 |
| Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction SD Solomon, JJV McMurray, B Claggett, RA de Boer, D DeMets, ... New England Journal of Medicine 387 (12), 1089-1098, 2022 | 1982 | 2022 |
| Recognition and initial management of fulminant myocarditis: a scientific statement from the American Heart Association RD Kociol, LT Cooper, JC Fang, JJ Moslehi, PS Pang, MA Sabe, RV Shah, ... Circulation 141 (6), e69-e92, 2020 | 600 | 2020 |
| Effects of sacubitril-valsartan versus valsartan in women compared with men with heart failure and preserved ejection fraction: insights from PARAGON-HF JJV McMurray, AM Jackson, CSP Lam, MM Redfield, IS Anand, J Ge, ... Circulation 141 (5), 338-351, 2020 | 383 | 2020 |
| Influence of baseline and worsening renal function on efficacy of spironolactone in patients with severe heart failure: insights from RALES (Randomized Aldactone Evaluation Study) O Vardeny, DH Wu, A Desai, P Rossignol, F Zannad, B Pitt, SD Solomon, ... Journal of the American College of Cardiology 60 (20), 2082-2089, 2012 | 302 | 2012 |
| Clinical characteristics and outcomes of hospitalized women giving birth with and without COVID-19 KS Jering, BL Claggett, JW Cunningham, N Rosenthal, O Vardeny, ... JAMA internal medicine 181 (5), 714-717, 2021 | 291 | 2021 |
| Reduced risk of hyperkalemia during treatment of heart failure with mineralocorticoid receptor antagonists by use of sacubitril/valsartan compared with enalapril: a secondary … AS Desai, O Vardeny, B Claggett, JJV McMurray, M Packer, K Swedberg, ... JAMA cardiology 2 (1), 79-85, 2017 | 238 | 2017 |
| Combined neprilysin and renin-angiotensin system inhibition for the treatment of heart failure O Vardeny, R Miller, SD Solomon JACC: Heart Failure 2 (6), 663-670, 2014 | 233 | 2014 |
| Efficacy of sacubitril/valsartan vs. enalapril at lower than target doses in heart failure with reduced ejection fraction: the PARADIGM‐HF trial O Vardeny, B Claggett, M Packer, MR Zile, J Rouleau, K Swedberg, ... European journal of heart failure 18 (10), 1228-1234, 2016 | 228 | 2016 |
| Incidence, predictors, and outcomes related to hypo-and hyperkalemia in patients with severe heart failure treated with a mineralocorticoid receptor antagonist O Vardeny, B Claggett, I Anand, P Rossignol, AS Desai, F Zannad, B Pitt, ... Circulation: Heart Failure 7 (4), 573-579, 2014 | 205 | 2014 |
| Deprescribing for Community-Dwelling Older Adults: a Systematic Review and Meta-analysis HE Bloomfield, N Greer, AM Linsky, J Bolduc, T Naidl, O Vardeny, ... Journal of general internal medicine 35, 3323-3332, 2020 | 187 | 2020 |
| Reduced loop diuretic use in patients taking sacubitril/valsartan compared with enalapril: the PARADIGM‐HF trial O Vardeny, B Claggett, J Kachadourian, AS Desai, M Packer, J Rouleau, ... European journal of heart failure 21 (3), 337-341, 2019 | 186 | 2019 |
| Heart failure drug treatment—inertia, titration, and discontinuation: a multinational observational study (EVOLUTION HF) G Savarese, T Kishi, O Vardeny, S Adamsson Eryd, J Bodegård, LH Lund, ... Heart Failure 11 (1), 1-14, 2023 | 184 | 2023 |
| Influenza vaccination in patients with chronic heart failure: the PARADIGM-HF trial O Vardeny, B Claggett, JA Udell, M Packer, M Zile, J Rouleau, ... JACC: Heart Failure 4 (2), 152-158, 2016 | 181 | 2016 |
| Kidney function and outcomes in patients hospitalized with heart failure RB Patel, GC Fonarow, SJ Greene, S Zhang, B Alhanti, AD DeVore, ... Journal of the American College of Cardiology 78 (4), 330-343, 2021 | 158 | 2021 |
| Finerenone in heart failure with mildly reduced or preserved ejection fraction SD Solomon, JJV McMurray, M Vaduganathan, B Claggett, PS Jhund, ... New England Journal of Medicine 391 (16), 1475-1485, 2024 | 157 | 2024 |
| Clinical outcomes in patients with heart failure hospitalized with COVID-19 AS Bhatt, KS Jering, M Vaduganathan, BL Claggett, JW Cunningham, ... Heart Failure 9 (1), 65-73, 2021 | 153 | 2021 |
